Moracin M inhibits EV71 infection primarily by blocking viral attachment to host cells
Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)
DOI: 10.1128/aac.01932-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Yinying Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cognitive and Affective Disorders, Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China. Hauptthemen laut MEDLINE: Antiviral Agents, Enterovirus A, Human, Hand, Foot and Mouth Disease, Virus Attachment. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research Start-up Funds of Jianghan University, Scientific Research Project Funding of Jianghan University.
Abstract (Originalsprache)
The global outbreak of hand, foot, and mouth disease (HFMD), mainly caused by enterovirus A71 (EV71) and coxsackievirus A16 (CA16) of the genus enterovirus, poses a serious threat to the health of young children, and severe neurological manifestations and associated symptoms are primarily attributed to EV71 infection. There is currently no specific antiviral drug available for HFMD. In this study, we identified Moracin M (MM), a flavonoid compound derived from Smilax china , as a potent inhibitor of EV71 and CA16 infection. Mechanistic investigation revealed that MM exerts its antiviral effects primarily by inhibiting viral attachment to host cells by targeting the virus. Furthermore, MM showed excellent safety and significant anti-EV71 activity in neonatal mice, and it also effectively suppressed the inflammatory response and alleviated muscle, lung, and brain tissue damage induced by EV71 infection. In conclusion, our study identified and demonstrated MM as a promising inhibitor of EV71 and CA16, providing important insights for the further development of MM as a potential therapeutic agent for HFMD caused by these viruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Cognitive and Affective Disorders, Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan, China.
- Hubei Provincial Demonstration Center for Experimental Medicine Education, School of Medicine, Jianghan University, Wuhan, China.
- Department of Immunology, School of Medicine, Jianghan University, Wuhan, China.
ORCID-Profile: Yinying Zhu, Pin Wan, Binlian Sun
Förderung
- Scientific Research Start-up Funds of Jianghan University
- Scientific Research Project Funding of Jianghan University
Zitieren
APA
Zhu, Y., Peng, Q., Hu, L., Li, W., Shi, Y., Ye, X., Shu, X., Liu, Y., Liu, W., Wan, P., & Sun, B. (2026). Moracin M inhibits EV71 infection primarily by blocking viral attachment to host cells. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.01932-25
Vancouver
Zhu Y, Peng Q, Hu L, Li W, Shi Y, Ye X, et al. Moracin M inhibits EV71 infection primarily by blocking viral attachment to host cells. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.01932-25
BibTeX
@article{Zhu2026,
author = {Zhu, Yinying and Peng, Qian and Hu, Lijuan and Li, Weiling and Shi, Yingying and Ye, Xiansheng and Shu, Xiji and Liu, Yuchen and Liu, Wei and Wan, Pin and Sun, Binlian},
title = {Moracin M inhibits EV71 infection primarily by blocking viral attachment to host cells},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {7},
doi = {10.1128/aac.01932-25}
}
EUVIMED